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Cells with many of  the features of  mast cells develop in cultures of  normal 
mouse hematopoietic cells containing mast cell growth factor (1-8), an activity 
similar or identical to interleukin 3 (IL-3) ~ (9-11), histamine-producing cell- 
stimulating factor (9), or P cell-stimulating factor (12-14). Large numbers of 
these cells (>10 s) can be generated as virtually homogeneous populations or as 
clones, thereby facilitating a wide variety of  biochemical and functional studies 
(reviewed in 15). Yet, despite their popularity as an experimental model, the 
precise relationship of  these cells to mast cell populations observed in vivo is 
controversial. 
It has been clear from the beginning that the cultured cells differ in certain 
important respects from the best-characterized cell type available for detailed 
comparative studies: mature peritoneal mast cells (reviewed in 15). Cultured 
mast cells appear immature by ultrastructure (1, 2, 15), contain low levels of  
histamine (1, 2, 5, 12, 15-18), and express fewer surface receptors for IgE than 
do mature peritoneal mast cells (2). In addition, cultured mast cells incorporate 
Na235804 into granule-associated chondroit in sulfates (2, 10, 17, 19), including 
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an oversulfated chondroitin that is designated chondroitin sulfate E (10, 19). By 
contrast, normal mouse peritoneal mast cells synthesize heparin (2, 19). 
However, peritoneal mast cells are representative of only one of two pheno- 
typically distinct mast cell populations that have been identified in murine 
rodents. Maximow was probably the first to recognize that certain mast cells in 
the rat intestinal mucosa were atypical, in that their staining characteristics 
differed from those of mast cells observed in other anatomical sites (20). Enerbfick 
greatly extended these observations and defined conditions of fixation and 
histochemical staining that discriminated between such atypical or mucosal mast 
cells (MMC) and the connective tissue type mast cells (CTMC) of the skin, 
peritoneal cavity, and other sites (21). 
We (1, 2, 15) and several other investigators (10, 14, 17) have noted that 
cultured murine mast cells express certain characteristics similar to those of 
MMC. MMC contain low levels of histamine (21, 22), and microspectrophoto- 
metric evidence suggests that their granules contain a poorly sulfated glycosami- 
noglycan similar to chondroitin sulfate (23). Cultured mast cells and MMC also 
exhibit similar patterns of responsiveness to certain secretagogues (I 7) and, in 
the rat, contain a similar or identical granule-associated protease (24). 
Furthermore, the growth of both cultured mast cells and MMC may be 
regulated by similar signals. Mucosal mast cells are exquisitely sensitive to T cell 
regulation. Striking proliferation of MMC occurs during T cell-dependent 
responses to certain intestinal parasites in normal mice and rats (for reviews, see 
15, 21, 25-27). By contrast, athymic nude mice lack such a response (28). The 
nude mouse intestinal mucosa contains MMC precursors (27), however, and 
MMC proliferation does occur if nude mice are reconstituted with T cells before 
intestinal infection (28). Cultured mast cells proliferate in response to mast cell 
growth factor (IL-3), which can be elaborated by cloned Ly-l+2 - inducer T cells 
(i-4). In addition, Crapper et al. (29) reported that the survival of cultured mast 
cells injected into the skin of (B10pd X DBA/2)F1-Wf/Wf(BIOD2F1-Wf/W f) mast 
cell-deficient mice required that the mice also contain a subcutaneous inoculum 
of the WEHI-3B tumor as a source of mast cell growth factor. 
Although some authors have suggested that cultured mast cells may be com- 
mitted to express the MMC phenotype, we (1, 2, 15) and Yung and Moore (8) 
entertained an alternative hypothesis: that many of the properties of cultured 
mast cells might reflect their immaturity. However, attempts to induce further 
maturation of cultured mast cells in vitro met with only limited success. The 
inducing agent sodium butyrate caused a marked inhibition of cultured mast cell 
proliferation, resulted in increased storage of histamine and chondroitin sulfate, 
and favored partial maturation of cytoplasmic granules (2, 30). But the cells did 
not appear fully mature by ultrastructure nor did they synthesize detectable 
amounts of heparin. 
In the present study, we adopted a different strategy: we injected cultured 
mast cells directly into mast cell-deficient (WB X C57BL/6)FI-W/W v (WBB6F1- 
W/W v) mice and examined the cells' histochemical characteristics and ultrastruc- 
ture at different intervals up to 10 wk later. We performed similar experiments 
using partially purified peritoneal mast cells from WBB6F~-+/+ mice. When 
injected in vivo, cultured or peritoneal mast cells gave rise to mast cells in several 
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different anatomical sites. In the peritoneal cavity, skin, spleen, and glandular 
stomach muscularis propria, these mast cells exhibited features of  CTMC.  By 
contrast, adoptively transferred mast cells identified in the mucosa of  the glan- 
dular stomach resembled MMC. These results suggest hat mast cell phenotype 
can be strikingly influenced by local microenvironmental  f ctors. 
Mater ia ls  and  Methods  
Mice. The tissues of adult WBB6F1-W[W v mice contain <1% the number of CTMC 
as do their normal (+/+) littermates (31, 32). WBB6F1-W/W v mice also lack MMC (33). 
Both of these populations can be restored by transplantation f bone marrow cells derived 
from WBB6FI-+/+ mice (31-33). WBB6Fl- (W/W ~, +/+) and C57BL/6-bgJ/bg J mice were 
raised at the Osaka University Medical School or Shizuoka Laboratory Animal Center. 
Cells derived from C57BL/6-bgJ[bg J mice were used in some experiments because their 
giant granules represent a morphologic marker that can unequivocally identify the cells 
as of donor origin (34, 35). The original stocks of  mutant mice were obtained from The 
Jackson Laboratory, Bar Harbor, ME, but W v and bg J mutant genes have been maintained 
in C57BL/6 mice of our own inbred colony (more than 29 and 16 backcrosses, respectively, 
at the time of the present experiments) (36, 37). Mice were used at 2-6 mo of age. 
Cell Suspensions. Mice were killed by decapitation. Bone marrow cells were recovered 
and suspended in Eagle's medium as described previously (38). To harvest peritoneal 
cells, 2 ml of Eagle's medium containing 10 IU/ml heparin and 0.1% bovine serum 
albumin (BSA) was injected into the peritoneal cavity, and the abdomen was massaged 
gently for 30 s. The peritoneal cavity was carefully opened, and the fluid containing 
peritoneal cells was aspirated with a pasteur pipette. When peritoneal cells were used for 
microscopical observations, heparin was omitted from the Eagle's medium, which was 
injected into the peritoneal cavity. 
Cell Counts. Cells were counted in a standard hemocytometer. Peritoneal and cultured 
mast cells were identified either by staining with neutral red (0.02% in 0.9% NaCI) or by 
using phase contrast microscopy. These methods gave similar results. 
Conditioned Medium. Pokeweed mitogen (Gibco Laboratories, Grand Island, NY)- 
stimulated spleen cell-conditioned medium (PWM-SCM) was prepared according to the 
method described in Nakahata et al. (39). Spleen cells were incubated for 5 d at 2 × 106 
cells/ml in a medium (Flow Laboratories, Irvine, Scotland) containing a 1:300 dilution of 
PWM, 10% fetal bovine serum (Irvine Scientific, Santa Ana, CA), 10 -4 M 2-mercaptoeth- 
anol (Sigma Chemical Co., St. Louis, MO). The conditioned medium was centrifuged, 
filtered through a 0.22 ~tm filter (Millipore Corp., Bedford, MA), and stored at -80°C. 
Culture of Mast Cells. Bone marrow cells were cultured at 106/ml in a medium 
supplemented with 10 -4 M 2-mercaptoethanol, 20% horse serum (Sterile Systems, Inc., 
Logan, UT) and 10% PWM-SCM. Culture flasks (Nunc, Roskilde, Denmark) were 
incubated at 37°C in a humidified atmosphere of 5% CO2, 95% air. Half of the medium 
was replaced every 7 d. The cells were washed and resuspended in Eagle's medium for 
injection in vivo. 
Separation of Peritoneal Mast Cells. The method has been described in detail (40). 
Briefly, most mouse peritoneal cells are macrophages and small ymphocytes. Macrophages 
were removed with a magnet after being permitted to ingest carbonyl iron (GAF Co., 
New York). Small lymphocytes and mast cells then were separated by Percoll density 
gradient centrifugation. After centrifugation, mast cells (30-50% pure) were washed and 
resuspended in Eagle's medium for injection in vivo. 
Cell Injection. Cultured or peritoneal mast cells were injected into the skin, peritoneal 
cavity, or tail vein of WBB6FI-W/W ~ mice. To facilitate direct injections of cells into the 
skin, an area of dorsal skin was shaved with hair clippers. Cells (in 0.05 ml Eagle's medium 
per site) were injected with a tuberculin syringe. Each mouse received six injections, which 
were marked by mixing India ink with the suspension medium. Intraperitoneal nd 
intravenous injections were done with injection volumes of 0.5 and 0.2 ml, respectively. 
Limiting Dilution Analysis of Mast Cell Precursors. The principle of the method has 
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been described in detail (41). WBB6F~-W/W v mice were killed 5 wk after the direct 
injection of cells into the skin. The dorsal skin was reflected; each injection site that could 
be identified by the presence of ink was removed in a 1.5 × 1 cm piece of skin, which 
then was attached to a piece of thick filter paper to keep it flat, and fixed in Carnoy's 
fluid (42). Skin pieces were embedded in paraffin; 25-#m-thick serial sections were cut 
parallel to the skin surface from the subcutaneous tissue to the epithelium, and the sections 
were stained with alcian blue-safranin (42). All of the serial sections were examined under 
the microscope to detect mast cell clusters, defined as a group of mast cells numbering 
>100 in its largest cross sections. When at least one mast cell cluster was identified, we 
assumed that the injected cell suspension had contained mast cell precursor(s). The 
concentration of mast cell precursors was calculated from the proportion of injection sites 
at which no clusters appeared (defined as the "proportion of nonappearance") for various 
cell doses by limiting dilution analysis as described by Finney (43), Porter and Berry (44), 
and Breivik (45). 
Assay of Spleen Colony-forming Units (CFU-S). The method of Till and McCulloch was 
used to determine the number of CFU-S (46). Cultured or peritoneal ceils of WBB6F1- 
+/+ mouse origin were injected intravenously into syngeneic mice irradiated (850 tad) as 
previously described (40). The mice were killed 8 d after cell injection; spleens were 
removed and fixed in Bouin's solution, and colonies were counted at a magnification of 
7× with a dissecting microscope. Each experiment contained at least 10 mice. 
Evaluation of Mast Cell Development, Morphology, and Histochemistry. Mice were killed 
at various intervals after intraperitoneal or intravenous injection of cells. Peritoneal cells 
were harvested as described above, and were spun in the cytocentrifuge. A piece of dorsal 
skin, and the spleen and the stomach were removed. The cytocentrifuge preparations and 
the tissues were fixed in Carnoy's fluid. Paraffin sections (10 #m) of tissues were made by 
routine methods and were stained with alcian blue-safranin. Mast cells in the skin, spleen, 
and glandular stomach were counted as described previously to determine whether 
successful transfer and development of mast cells had occurred (32, 47). ~105 cells were 
examined in cytocentrifuge preparations of peritoneal cells after staining with alcian blue- 
safranin. We judged that successful transfer of mast cells to the peritoneal cavity had 
occurred if mast cells represented >0.1% of the peritoneal cells. 
Mast Cell Staining with Berberine Sulfate. In most experiments, representative cytocen- 
trifuge preparations and tissue specimens were stained with the fluorescent dye berberine 
sulfate (Sigma Chemical Co.), as described by Enerbfick (48), and were examined in an 
epifluorescence microscope (Olympus Corp., Tokyo). Under these conditions of fixation 
and staining, the cationic dye selectively binds to phosphate- and/or sulfate-containing 
polyanions, including DNA and heparin (48). However, staining of DNA and heparin are 
distinguishable because heparin-bound berberine sulfate exhibits rapid fading upon con- 
tinuous illumination whereas DNA-bound dye slowly increases in fluorescence intensity 
(48). Furthermore, when heparin-containing mast cells are examined, the cytoplasmic 
granules exhibit bright yellow fluorescence whereas the nucleus appears a dull green (48). 
Dimlich et al. (49) demonstrated that berberine sulfate staining of tissue sections of rats 
or mice at pH 4.0 identified connective tissue type mast cells, such as those in the skin. 
By contrast, berberine sulfate did not stain mast cells in the gastric mucosa (49). 
Even though bright cytoplasmic staining with berberine sulfate at pH 4.0 appears to be 
highly selective for heparin-containing mast cells, we provided further evidence that the 
dye was identifying heparin in our preparations, by treating some specimens either with 
heparinase (heparin lyase from Flavobacterium heparinum; Seikagaku Chemical Industry 
Co. Ltd., Tokyo) or with chondroitinase ABC (chondroitin ABC lyase from Proteus 
vulgaris; Seikagaku Chemical Industry) before staining. For treatment with enzymes, 
specimens were fixed in chilled calcium acetate formalin at 4°C for 18 h according to 
Yamada (50) and overlayed with Tris-HCl buffer (0.1 M) containing either heparinase 
(0.5 IU/ml, pH 7.0) or chondroitinase ABC (5.0 IU/ml, pH 8.0). After washing away the 
enzyme solutions with Tris-HCl buffer of the same pH, specimens were stained with 
berberine sulfate. In control experiments, treatment with heparinase for 30 rain abolished 
the berberine sulfate-dependent fluorescence of granules of freshly isolated peritoneal 
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mast cells, whereas treatment with chondroitinase ABC for 4 h did not. Treatment of 
specimens with either of the buffer solutions (pH 7.0 or 8.0) alone had no effect on the 
berberine sulfate staining. 
In some cases, mast cells were counted after staining with berberine sulfate, and then 
the same specimens were stained with alcian blue; mast cells in the same optical field were 
counted again, and the ratio of berberine sulfate-positive mast cells to alcian blue-positive 
mast cells was calculated. 
Electron Microscopy. Cultured cells or peritoneal cells were centrifuged at 500 g for 10 
min. The cell pellets were fixed with 3% glutaraldehyde in 0.I M cacodylate buffer (pH 
7.4) at room temperature for 45 min, and were washed with 0.1 M cacodylate buffer 
containing 4.5% sucrose. The cells were postfixed with 1% osmium tetroxide in veronal 
acetate buffer (pH 7.4) for 1 h at 4°C, dehydrated in a graded series of ethanol followed 
by acetone, and embedded in Epon 812. Ultrathin sections were cut with an ultramicro- 
tome (LKB Instruments, Inc., Gaithersburg, MD), stained with uranyl acetate and lead 
citrate, and examined with a Hitachi HU-12 electron microscope. 
Histamine Content. Prior to assay, small aliquots of the cultured or peritoneal cells 
were taken to determine the number of mast cells present; the remaining cells were stored 
at -80°C. Histamine concentration was assayed by high performance liquid chromatog- 
raphy coupled with fluorometry as described by Yamatodani et al. (51), and the content 
of histamine per 106 mast cells was calculated. 
Resul ts  
Development of Mast Cells and Mast Cell Precursors in Suspension Culture 
Bone marrow cells of  WBB6F I -+/+ mice were cultured in the presence of 
10% PWM-SCM. Aliquots of  the cultured cells were harvested when half of  the 
medium was changed and the concentrations of  CFU-S, mast cell precursors, 
and morphological ly identifiable mast cells were determined. The  number  of 
CFU-S decreased exponentially, and none were detectable 3 wk after initiation 
of  the culture (Fig. 1). By contrast, the numbers of  mast cell precursors and 
morphological ly identifiable mast cells increased rapidly. 4 wk after initiation of  
the culture, ~2% of  the cultured cells had the ability to form mast cell clusters 
in the skin ofWBB6F1-W/W v mice, and >95% of  the cultured cells were identified 
as immature mast cells (Fig. 1). The  immature mast cells stained with alcian blue, 
but with neither safranin or with berber ine sulfate (Fig. 2, Table I). 
To  determine the concentrations of  mast cell precursors reported in Fig. 1, 
WBB6FrW/W ~ recipient mice were killed 5 wk after the direct cutaneous 
injection of  cells harvested 4 wk after the initiation of  culture. In one experiment,  
WBB6F~-W/W ~mice were killed 10 wk after the injection o f  cultured mast cells. 
Mast cell clusters persisted at the skin injection sites in these mice, and most of  
the mast cells in the clusters stained with berber ine sulfate. Some of  these mast 
cells also stained with safranin. 
Intraperitoneal Injection of Cultured Mast Cells 
Characteristics of mast cells recovered from the peritoneal cavity. Cultured mast 
cells of  WBB6F I -+/+ mouse origin were harvested 4 wk after the initiation of  
the culture and 106 cells were injected into the peritoneal cavity of  each WBB6Fr  
W/W v mouse. Peritoneal cells of  the recipient mice were recovered at various 
times for preparat ion of  cytocentri fuge specimens or for electron microscopy. 
Mast cells that stained with berber ine sulfate were observed 3 wk after intraper- 
itoneal injection and, by 10 wk, accounted for ~90% of  the recovered cells 
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FIGURE 1. Concentrations of total cells, morphologically identifiable mast cells, CFU-S, and 
mast cell precursors, at various times after the initiation of suspension culture of WBB6F~-+/ 
+ mouse bone marrow cells (10S/ml) in 10% PWM-SCM. Cells were fed by replacement of 
half of the medium every week; cell concentrations were determined at that time. 
(Table I, Fig. 2). Berberine sulfate staining of the recovered mast cells was 
prevented by first incubating the cells with 0.5 IU/ml of heparinase for 30 min 
(Fig. 2). By contrast, incubation of the cells with the heparinase buffer solution, 
or with 5 IU/mi of chondroitinase ABC for 4 h, did not significantly affect the 
intensity of berberine sulfate staining (Fig. 2). 
In addition to acquiring the ability to stain with berberine sulfate, the recovered 
cells exhibited other alterations in phenotype when compared with cultured mast 
cells studied before adoptive transfer. Thus, mast cells studied 10 wk after 
intraperitoneal injection stained with safranin and exhibited ultrastructural fea- 
tures similar to those of mature peritoneal mast cells recovered from normal 
WBB6Fv+/+ mice (Fig. 2). Moreover, mast cell histamine content progressively 
increased after intraperitoneal injection (Table I). 
Two experiments were done to exclude the possibility that intraperitoneal 
injection of cultured mast cells might induce the development of mast cells of 
WBB6F1-W/W v (recipient) origin. First, we injected cultured mast cells (106) of 
C57BL/6-gb J /bg  J mouse origin into the peritoneal cavity ofWBB6F I -W/W v mice. 
10 wk after injection, most of the mast cells stained with berberine sulfate and 
many of them stained with safranin. All of the recovered mast cells exhibited the 
giant cytoplasmic granules characteristic of the bgJilbg J mutation. 
For the second experiment, bone marrow cells of either WBB6FwW/W v or 
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FIGURE 2. (A-D) Cytocentrifuge preparations stained with berberine sulfate. (A) Cultured 
mast cells 4 wk after initiation of culture; only nuclei showed faint fluorescence. × 400. (B) 
Peritoneal cells recovered from a WBB6F1-W/W v mouse 10 wk after the intraperitoneal 
injection of 10 e cultured mast cells of WBB6FI-+/+ mouse origin. The cytoplasm of the mast 
cells exhibited intense fluorescence. × 400. (C) A specimen made from the same cell suspension 
shown in B, but treated with chondroitinase ABC before staining. Bright cytoplasmic fluores- 
cence of mast cells was retained. × 200. (D) A specimen made from the same cell suspension 
shown in B and C, but treated with heparinase before staining. Heparinase treatment abolished 
staining of mast cells by berberine sulfate. X 200. (E) The ultrastructure of a cultured mast 
cell 4 wk after initiation of the culture. The cytoplasmic granules exhibited heterogeneous 
content. × 5,800. (F) Ultrastructure of a mast cell recovered from the peritoneal cavity of a 
WBB6FrW/W ~ mouse 10 wk after intraperitoneal injection of cultured mast cells. The 
cytoplasmic granules appear uniformly electron dense. × 5,800. 
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TABLE I 
Proportion of Berberine Sulfate-positive C lls and Histamine Content 
of Mast Cells Recovered from the Peritoneal Cavity of WBB6F I-W/W ~ 
Mice After Intraperitoneal Injection of 108 Cultured Mast Cells of 
WBB6F I-+ / + Mouse Origin 
Type of cells 
Berberine sulfate- 
positive cells as a 
percent of alcian 
blue-positive cells* 
Histamine content of 
peritoneal cells* (ng/ 
106 mast cells) 
Cultured mast cells 
Before i.p. injection <0.1'  (7) 120 __. 9 (4) 
1 wk after <0.1 * (7) 430 ± 100 (4) 
3 wk after 5 ± 1 (6) i 470 + 130 (7) 
5 wk after 60 ± 11 (5) ! 1,540 ± 310 (6) ! 
10 wk after 93 ± 3 (I0) ! 2,730 ± 140 (8) ! 
Peritoneal mast cells of 98 ± 5 (5) 13,800 ± 2,100 (7) 0 
WBB6FI-+/+ mice 
* Mean ± SE; number of mice is shown in parenthesis. 
* No berverine sulfate-positive c lls seen in >1,000 alcian blue-positive 
cells. 
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FIGURE 3. Comparison of in vitro growth of cultured mast cells of WBB6F~-W[W" or
WBB6Ft-+/+ mouse origin. Cultured mast cells were harvested 4 wk after initiation of the 
original cultures, which had been maintained in medium supplemented with 10% PWM-SCM. 
The W/W" or +/+ cells were then incubated (3.0 x 104 cells/ml) with various concentrations 
of PWM-SCM for 1 wk, after which the number of mast cells was determined. 
WBB6FI-+/+ mice were cultured in the presence of PWM-SCM. As was reported 
by Yung and Moore (7), mast cells developed in both cultures. Like WBB6F]-+/ 
+ cells, cultured mast cells of WBB6F] -W/W ~ origin stained with alcian blue but 
with neither safranin or berberine sulfate. 4 wk after the initiation of culture, 
we compared the growth response of the two populations by placing the cells in 
various concentrations of PWM-SCM. No significant differences between the 
responses of WBB6F] -W/W ~ and -+/+ cells were observed (Fig. 3). Although the 
experiment shown in Fig. 3 used PWM-SCM prepared with WBB6FI-+/+ cells, 
an experiment using PWM-SCM prepared with WBB6Fx-W/W v cells gave similar 
results (data not shown). 
In striking contrast o the results obtained in vitro, marked differences in the 
behavior of WBB6F1-W/W ~ and -+/+ cells were observed when the cultured 
mast cells were injected in vivo (Table II). Indeed, no mast cells of WBB6Ft-W/ 
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TABLE II 
Disappearance of Cultured Mast Cells of WBB6F rW]W ~ Mouse 
Origin After Transplantation i to the Peritoneal Cavity of 
WBB6FrW/W ~Mice 
Weeks after Genotype of No. of re- No. of mast cells per 
10 s peritoneal 
injection cultured cells cipients nucleated cells* 
1 +/+ 4 23.2 + 6.9 
W/W ~ 6 2.5 - 0.6* 
3 +/+ 6 26.3 - 3.5 
W/W ~ 7 0.6 - 0.3* 
5 +[+ 6 22.3 - 2.7 
W/W ~ 7 <0.1' 
10 +[+ 4 27.5 -+ 2.8 
W/W" 7 <0.1' 
Cultured mast cells were injected intraperitoneally into WBB6FrW/W ~ 
recipients (106 cells per mouse) 4 wk after the initiation of the cell 
cultures. 
* The results are shown as the mean + SE. 
*P < 0.01, when compared with the value for +/+ mice by t test. 
W ~ origin were detectable 3 wk after intraperitoneal injection, and no mast cells 
that stained with safranin or berber ine sulfate were detected at any intervals. 
Tissue Distribution and Characteristics of Mast Cells Recovered after 
Intraperitoneal Injection of Cultured or Peritoneal Mast Cells 
To  determine whether mast cells injected intraperitoneally might migrate to 
other anatomical sites, we injectd cultured mast cells of  WBB6Fr+/+ mouse 
origin into the peritoneal cavity of  WBB6F~-W/W v mice, and searched for mast 
ceils in various tissues of  these mice 10 wk later. Partially purif ied (30-50% pure) 
peritoneal mast cells, which, like our  preparations of  cultured mast cells, con- 
tained no detectable CFU-S (data not shown), were injected for comparison. 
Injection of  either cultured or peritoneal mast cells resulted in the development 
of  mast cells in the peritoneal cavity, spleen, skin, and glandular stomach (Table 
II I). Mast cells were detected more frequently in the muscularis propria; most of 
them were situated in the outer layer of  the muscle. 
Most mast cells in the peritoneal cavity, spleen, skin, and muscularis propria 
of  the stomach were stained with berber ine sulfate, and some of  them stained 
with safranin. By contrast, when mast cells were observed in the stomach mucosa, 
they stained only with alcian blue. In occasional sections, mast cells were observed 
in both the muscularis propria and the mucosa. In these stomachs, berberine 
sulfate- or safranin-positive mast cells were observed only in the muscularis. 
Tissue Distribution and Characteristics of Mast Cells Observed After 
Intravenous Injection of Cultured or Peritoneal Mast Cells 
10 wk after intravenous injection of  cultured or peritoneal mast cells of  
WBB6F~-+/+ origin, mast cells were observed in the peritoneal cavity, spleen, 
skin, and glandular stomach of  recipient WBB6Fl-W/W v mice (Table IV). As 
with intraperitoneal injections of  cells, most of  the mast cells observed in 
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TABLE I l l  
Appearance of Mast Cells in WBB6FrW/W v Mice 10 Wk After Intraperitoneal Injection of 
Cultured or Peritoneal Mast Cells of WBB6F r+/  + Mouse Origin 
Proportion of cases in which mast cells appeared 
Type of mast No. of 
cells cells Peritoneal Glandular stomach 
cavity Spleen Skin Muscle Mucosa 
Cultured* lO 2 0/5 0/5 0/5 0/5 0/5 
lO 3 2/5 0/5 0/5 3/5 0/5 
10 4 5/6 0/6 0/6 5/6 2/6 
l0 b 6/6 1/6 1/6 5/6 4/6 
Peritoneal* 10 3 2/10 o/ lo 0/10 0/10 0/10 
10 4 6/9 0/9 3/9 4/9 1/9 
lO s lO/lO lO/lO 3/10 9/10 5/10 
* Cultured mast cells were harvested 4 wk after the initiation of the culture. 
* Peritoneal mast cells were partially purified (30-50%); the number shown in the table refers to the 
number of mast cells injected. 
TABLE IV 
Appearance of Mast Cells in WBB6FrW/W ~Mice 10 Wk After Intravenous Injection of 
Cultured or Peritoneal Mast Cells of WBB6F I-+/+ Mouse Origin 
Proportion of cases in which mast cells appeared 
Type of mast No. of 
cells cells Peritoneal Glandular stomach 
cavity Spleen Skin Muscle Mucosa 
Cultured* 103 0/6 1/6 0/6 0/6 0/6 
104 0/5 1/5 0/5 0/5 0/5 
105 0/6 5/6 0/6 1/6 1/6 
l0 s 1/6 6/6 2/6 5/6 5/6 
Peritoneal* 10 3 0/8 3/8 0/8 0/8 0/8 
10 4 0/8 6/8 0/8 1/8 1/8 
lO 5 6/6 6/6 0/6 5/6 5/6 
* Cultured mast cells were harvested 4 wk after the initiation of the culture. 
* Peritoneal mast cells were partially purified (30-50%); the number shown in the table refers to the 
number of mast cells injected. 
connective tissue sites stained with berberine sulfate and some of them stained 
with safranin. But in the glandular stomach, berberin sulfate- or safranin-positive 
mast cells were observed only in the muscularis propria; all mast cells in the 
mucosa stained only with alcian blue (Fig. 4). Intravenous injection of cells 
resulted in the more frequent development of mast cells in the spleen than in 
the peritoneal cavity or stomach (Table IV). The opposite was true when cells 
were injected intraperitoneally (Table III). Intravenous injection of cultured or 
peritoneal mast cells had no measurable effect on the macrocytic anemia of the 
recipient WBB6FrW/W ~ mice (data not shown). 
Discussion 
The mast cells that developed in suspension cultures of mouse bone marrow 
cells supplemented with PWM-SCM resembled the growth factor-dependent 
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FIGURE 4. Glandular stomach of a WBB6F1-W[W ~mouse fixed 10 wk after the intravenous 
injection of 106 cultured mast cells of WBB6Fw+/+ mouse origin. The cultured mast cells 
had been harvested for injection 4 wk after initiation of the culture. (A) Stained with alcian 
blue-safranin. Many mast cells stained with alcian blue were observed in the mucosa.The area 
indicated by the arrow isshown in higher magnification in B. (C) The same section stained 
with berberine sulfate; only mast cells in the muscle layer showed bright cytoplasmic fluores- 
cence. The area indicated by the arrow is shown in higher magnification D. (A and C) x 100. 
(B and D) x 1,000. 
mast cells characterized in the laboratory of S. J. Galli (1, 2, 15) and by several 
other investigators (5-7,  10, 12-14,  16-18,  39, 52). The  cells had the ultrastruc- 
tural features of  immature mast cells, contained low levels of  histamine, and 
synthesized cytoplasmic granules that stained with alcian blue but with neither 
safranin or with berberine sulfate. We found that, as the number  of  morpholog- 
ically identifiable mast cells in the cultures increased, the number  of  cells capable 
of  giving rise to mast cell clusters when injected into the skin of WBB6FI -W/W v 
mice increased roughly in parallel. Such mast cell precursors represented ~1% 
of  the cells present 4 -5  wk after the initiation of culture. By contrast, the number  
of  CFU-S decreased exponentially, and none were detectable after 3 wk of 
culture. 
Mast cell clusters were identifiable in the skin of WBB6F1-W/W v mice examined 
even 10 wk after intracutaneous injection of  the cultured cells. Some of  these 
mast cells stained with safranin and most of  them stained with berberine sulfate, 
a pattern mimicking that of  normal cutaneous mast cells o f  the connective tissue- 
type (21, 48, 49). By contrast, Crapper  et al. (29) found that cultured mast cells 
derived f rom B10.D2 or  C57BL/6 J -bg J /bg  J mice did not survive >2 wk after 
injection into the skin of  BIOD2F1-Wf /W f mice. I f  the recipient mice bore a 
subcutaneous inoculum of  the IL-3-producing WEHI -3B tumor,  mast cells sur- 
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vived in the skin for 4 wk after injection (29). But these mast cells stained only 
with alcian blue; no safranin-positive mast cells were observed. 
The discrepancy between our results and those of Crapper et al. (29) may be 
attributable to differences in the host animals. The mast cell deficiency of 
BIOD2F I -WY/W y mice is not as severe as that of WBB6F~-W/W"  mice (29). We 
found that, when mast cell precursors of C57BL/6-bgJ /bg J mouse origin were 
injected into the skin of different mice doubly heterozygous for mutations at the 
W locus (e.g., WBB6F1-W"/W j, -W" /W ~h, and -W/W~), the frequency of develop- 
ment and size of mast cell clusters were inversely proportional to the concentra- 
tion of mast cells in the skin of the host mice (unpublished ata). Whatever the 
explanation for the differences between our findings and those of Crapper et al. 
(29), our data indicate that exogenous ources of IL-3 or other growth factors 
are not required for the survival of cultured WBB6F~-+/+ mast cells in WBB6F~- 
W/W ~ mice. In addition, our histochemical findings indicate that cultured mast 
cells injected directly into the skin of WBB6F~-W/W v mice acquire at least some 
of the characteristics of mature CTMC. 
An analogous result was obtained when cultured mast cells were injected into 
the peritoneal cavity of WBB6Fa-W/W ~ mice. Many of the mast cells recovered 
5 wk after intraperitoneal injection of cultured cells were safranin and berberine 
positive; by 10 wk, ~90% of the mast cells stained with berberine sulfate. In 
addition, the histamine content of the recovered mast cells was substantially 
increased compared with that of cells taken directly from culture, and the 
recovered cells closely resembled normal mature peritoneal mast cells by ultra- 
structure (53). 
Two lines of evidence indicate that the mast cells recovered from the peritoneal 
cavity of recipient WBB6F1-W/W ~ mice were derived from the injected cultured 
ceils. First, when the experiment was performed using cultured mast cells of 
C57BL/6-bgJ /bg J origin, the mast cells recovered 10 wk later contained the giant 
cytoplasmic granules characteristic of the beige mutation. Second, when cultured 
mast cells derived from WBB6F I -W/W ~ mice were injected, identifiable mast 
cells were no longer present 5 wk after intraperitoneal injection. The latter 
finding argues against he notion that the mast cell recovered from the peritoneal 
cavity of WBB6F1-W/W ~ mice injected with cultured mast cells of WBB6FI-+/+ 
origin, were of host origin. 
The differences in the behavior of WBB6F~-W/W ~and -+/+ mast cells after 
injection into WBB6F~-W/W ~ mice are of interest. Even though cultured mast 
cells derived from WBB6F~-W/W ~ or, -+/+ bone marrow cells gave similar 
responses to growth factors present in PWM-SCM when tested 4 wk after the 
initiation of culture, the WBB6F~-W/W ~mast cells could not survive as well as 
WBB6F~-+/+ cells after injection in vivo. This result may reflect a defect in the 
ability of cultured mast cells of WBB6F~-W/W ~origin to respond to growth or 
differentiation factors present in vivo but not in vitro. On the other hand, Yung 
and Moore (7) reported that cultured mast cells of WBB6F1-W/W ~ origin survive 
in culture less well than control cells of WBB6F~-W/+ origin, with differences 
between these populations first evident at about 5 wk of culture. This result 
raises the possibility that the disappearance of WBB6F~-W/W ~cells in vivo may 
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have occurred as a result of an intrinsic cellular defect hat can also be expressed 
in vitro. 
The phenotype of mast cells developing in the tissues of recipient mice after 
intravenous or intraperitoneal transfer of cultured cells varied predictably ac- 
cording to anatomical site. Many mast cells in the skin, spleen, or peritoneal 
cavity of recipient WBB6F2-W/W ~ mice stained with berberine sulfate, and some 
of them stained with safranin. These cells thus resembled by histochemistry the 
resident populations of CTMC observed at these sites in normal +/+ mice. The 
same was true when the histochemistry of mast cells developing in the stomachs 
of recipient WBB6FI -W/W ~ mice was considered. Like the mast cells in the 
mucosa of the glandular stomach of +/+ mice, the mast cells that developed in 
the gastric mucosa of recipient WBB6F~-W/W ~ mice stained only with alcian 
blue; none of the cells stained with either safranin or berberine sulfate. By 
contrast, many of the mast cells developing in the glandular stomach muscularis 
propria of recipient WBB6F~-W/W v mice stained with safranin and with berber- 
ine sulfate. 
Enerb/ick (48) and Dimlich et al. (49) demonstrated that berberine sulfate 
staining is highly specific for heparin-containing mast cells of the connective 
tissue type. We confirmed the specificity of the reaction in our material by 
demonstrating that the staining was prevented by prior treatment of the cells 
with heparinase but not chondroitinase ABC. These findings strongly suggest 
that cultured mast cells or their progeny acquire the ability to synthesize and 
store heparin when they are transplanted to appropriate anatomical locations in 
vivo. This represents an important observation, since under usual conditions of 
suspension culture (2, 10, 17, 19), or even when exposed to the inducing agent 
sodium butyrate (2), mouse mast cells synthesize chondroitin sulfates rather than 
heparin. It should be acknowledged, however, that histochemistry epresents an 
indirect approach to the identification of cellular constituents. It therefore will 
be important to use direct biochemical methods to confirm the presence of 
heparin in the mast cells. Evaluations of other aspects of the phenotype of the 
recovered cells, such as expression of membrane structures characteristic of 
cultured as opposed to normal peritoneal mast cells (10, 54) will also be of 
interest. 
Taken together, our histochemical nd ultrastructural evidence indicates that, 
after injection into WBB6F1-W/W ~ recipients, cultured mast cells and/or their 
progeny are able to acquire characteristics of either CTMC or MMC. Whether 
such phenotypic plasticity is a property of all cultured mast cells, or only a 
subpopulation, remains to be determined. Whatever the answer to this question 
may be, our observations argue against he notion that cultured mouse mast cell 
populations maintained under ordinary in vitro conditions are irrevocably com- 
mitted to the MMC phenotype. 
Several mechanisms might account for the expression of the two murine mast 
cell phenotypic patterns recognized in our experiments. One possibility is that 
the cultured cells (and immature mast cells in vivo) contain or can generate two 
distinct committed lineages, one of which gives rise to cells with the phenotype 
of MMC, the other of which gives rise to CTMC. Certain complex culture 
systems containing embryonic fibroblasts permit the expression of two mast cell 
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phenotypic patterns in vitro (55). However, ifcommittment to two separate mast 
cell lineages occurred in our experiments, it probably happened in vivo. First, 
cultured mast cell populations, even when not cloned, for the most part exhibit 
remarkably uniform characteristics (reviewed in 15). Expression of type II major 
histocompatibility complex (MHC) products may vary, but probably in response 
to differences in levels of soluble factors such as y-interferon (2, 5, 15, 56). 
Second, in a recent collaborative study with Dr. T. Nakahata nd his colleagues 
at Shinshu University, Matsumoto, Japan, we injected cloned mast cells derived 
from individual methylcellulose colonies into both the skin and the gastric mucosa 
of WBB6F~-W/W v mice (manuscript in preparation). The mast cells that devel- 
oped in the skin expressed the histochemical characteristics of CTMC, whereas 
the mast cells developing in the gastric mucosa stained only with alcian blue. 
This result indicated that each clone contained cells capable of generating both 
mast cell phenotypes. 
However, the occurrence of phenotypically distinct mast cell populations does 
not necessarily require the existence of distinct mast cell lineages. For example, 
a single lineage might give rise to populations whose phenotype varied according 
to such factors as stage of differentiation/maturation, a atomical location, or 
state of functional activity (15, 57). Our investigation of the development of mast 
cells after intraperitoneal or intravenous injection of representative, freshly 
isolated CTMC suggests that the phenotypic pattern ordinarily expressed by an 
individual mast cell population in vivo can be altered if those cells are transferred 
to a different anatomical location. 
After intravenous or intraperitoneal injection of partially purified (30-50% 
pure) peritoneal mast cells, we observed mast cells in both the connective tissues 
and gastric mucosa of WBB6F~-W/W ~recipients. Remarkably, the mast cells in 
the gastric mucosa stained only with alcian blue. The CFU-S represents a
precursor of the mast cell lineage (32, 47), but normal mouse peritoneal mast 
cells can exhibit extensive proliferative potential when injected intracutaneously 
into WBB6F I -W/W ~ mice (40). Taken together, these observations suggest hat 
the alcian blue-positive mast cells in the gastric mucosa were actually derived 
from the injected peritoneal mast cells, and raises the possibility that, under 
certain circumstances, CTMC give rise to cells with at least some of the features 
of MMC. The extent of alteration of peritoneal mast cell phenotype associated 
with location of the cells in the gastric mucosa, and the mechanisms regulating 
such changes, are currently under investigation. 
In addition to their relevance to the controversy about mast cell subsets, our 
observations suggest a new approach to the analysis of mast cell function. Mast 
cell-deficient mice represent a useful model for the analysis of mast cell biology 
in vivo. However, mast cell-deficient mice and their normal +/+ littermates 
differ in characteristics other than the number of mast cells: mast cell-deficient 
mice of W/W v genotype are anemic, sterile, and lack cutaneous melanocytes (3I). 
Adoptive transfer of WBB6F~-+/+ bone marrow into WBB6F~-W/W v mice 
produces an animal (+/+ --0 W/W v) whose mast cell defect is largely corrected, 
but whose anemia is cured as well (31, 32). Under certain circumstances, it may 
be difficult to determine whether an alteration of a particular biological response 
in +/+ --~ W/W ~ mice reflects the reconstitution of mast cells, normalization of 
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the hematocrit, or some other effect of transplantation of unfractionated bone 
marrow cells. However, cultured mast cell populations exhibit much more 
stringent lineage committment than do normal bone marrow cells. When tested 
after several weeks in vitro they contained undetectable l vels of CFU-S (present 
study) or erythroid burst-forming units (BFU-E) (H. Steinberg and S. J. Galli, 
unpublished ata). Furthermore, injection of cultured mast cells into WBB6F~- 
W/W ~ mice partially reconstituted mast cell populations without having any 
measurable effect on the recipient animals' macrocytic anemia. Transplantation 
of cultured mast cells into WBB6Fj-W/W' mice thus may represent an attractive 
strategy for selectively reconstituting the mast cell compartment of these animals. 
Summary 
Both connective tissue mast cells and mast cells grown in vitro are derived 
from muhipotential hematopoietic stern cells, but these two mast cell populations 
exhibit many differences in morphology, biochemistry, and function. We inves- 
tigated whether the phenotype of cultured mast cells or their progeny was altered 
when the cells were transferred into different locations in vivo. Cultured mast 
cells were immature by ultrastructure, and stained with alcian blue but with 
neither safranin or berberine sulfate, a fluorescent dye that binds to the heparin 
of connective tissue mast cell granules. By contrast, mast cells recovered from 
the peritoneal cavity of congenitally mast cell-deficient (WB × C57BL/6)F1-W/ 
W v (WBB6F1-W/W ~) mice 10 wk after intraperitoneal injection of cultured 
WBB6FI-+/+ or C57BL/6-bgJ/bg J mast cells stained with both safranin and 
berberine sulfate. Staining with berberine sulfate was prevented by treatment of 
the cells with heparinase but not chondroitinase ABC, suggesting that the 
adoptively transferred mast cell population had acquired the ability to synthesize 
and store heparin. Furthermore, the recovered mast cells were indistinguishable 
by uitrastructure from the normal mature peritoneal mast cells of WBB6F1-+/+ 
mice, and contained substantially more histamine than mast cells studied directly 
from culture. 
Intravenous injection of cultured mast cells resulted in the development of 
safranin- and berberine sulfate-positive mast cells in the peritoneal cavity, spleen, 
skin, and glandular stomach muscularis propria. Mast cells also developed on the 
glandular stomach mucosa, but these cells stained with alcian blue rather than 
safranin, and did not stain with berberine sulfate. This result suggests that 
cultured mast cells can give rise to mast cells of either the connective tissue type 
or mucosal phenotype, depending on anatomical location. Furthermore, trans- 
plantation of cultured mast cells into WBB6F~-W/W ~ mice had no measurable 
effect on the anemia of the recipient mice, suggesting a possible strategy for 
repairing the mast cell deficiency of WBB6F~-W/W ~ mice without affecting other 
bone marrow-derived populations uch as erythrocytes. 
Intravenous injection of representative connective tissue type mast cells (30- 
50% pure peritoneal mast cells derived from WBB6Fl-+/+ mice) gave results 
similar to those obtained with cultured mast cells: mast cells developing in the 
peritoneal cavity, skin, spleen, and glandular stomach muscularis propria of 
WBB6F1-W/W ~recipients tained with safranin and berberine sulfate, whereas 
mast cells developing in the mucosa of the glandular stomach stained only with 
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alcian blue. This result offers further support to the notion that mast cell 
phenotype may be regulated, at least in part, by the tissue microenvironment.  
We acknowledge the valuable discussions with Drs. S. Suzuki and Y. Nakanishi of Nagoya 
University and Dr. G. Eguchi of the National Institute of Basic Biology. 
Received for publication 4 June 1985. 
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